Opgelet! Uw huidige locatie komt niet overeen met het gekozen land.
Wenst u het gekozen land te veranderen?

Attention! Votre localisation ne correspond pas au pays choisi.
Désirez-vous changer le pays sélectionné ?
Achtung! Ihre Ortsangabe passt nicht zum gewählten Land.
Möchten Sie ein anderes Land wählen?

Attention! Your location does not correspond with the chosen country.
Do you wish to change your country?
Attention! Your location does not correspond with the chosen country.
Do you wish to change your country?
No
Yes

Select your location and language:

No

Log in

: :


Nog geen wachtwoord?

No
Metagenics Belgium BVBA

Find your product alphabetically:

A unique model for product development

The platform of MetaProteomics to develop products, is the ExpresSyn process. This patented process, developed to guarantee the efficiency and predicted safety of our nutritional formulas, combines the best of all medical, biotechnological and pharmacologic research techniques and Metagenics' profound knowledge of natural ingredients.
 

The ExpresSyn Process involves the following processes:

  •  
  • - Ingredient Discovery. The health-supporting properties of hundreds of natural compounds and compound mixtures derived from foods, spices, and herbs with a long history of safe use are identified via in vitro enzyme assays, cell culture models, and other forms of testing.
  •  
  • - Proof of Concept. Additional testing is conducted to provide preliminary confirmation of the desired clinical target. The formulas with acceptable safety profiles at therapeutic doses are evaluated for bioavailability and metabolism in humans.
  •  
  • - Formula development. A source-safe pipeline of natural ingredients is identified, then products are formulated in the form (tablet, soft gel, or bar) that's most appropriate for the therapeutic target.
  •  
  • - Clinical experience. The new formula is evaluated for effectiveness using observational studies and random controlled studies